Alzheimer's a much larger cause of death than reported

A new U.S. study suggests that Alzheimer's disease and other dementias are markedly under-reported on death certificates and medical records. Death certificates tend to only provide an immediate cause, such as pneumonia, and don’t mention the underlying condition that provoked it.

The study involved 2,566 older adults (65+; mean age 78) who received annual testing for dementia. The death rate was more than four times higher for those aged 75-84 who had been diagnosed with Alzheimer’s, and nearly three times higher in those with Alzheimer’s aged 85+. More than one-third of all deaths in those age groups were attributable to Alzheimer's disease. Median time from Alzheimer’s diagnosis to death was 3.8 years.

All this translates into an estimated mortality rate from Alzheimer's that is five to six times higher than the accepted number (derived from death certificates), which has put Alzheimer’s as the 6th leading cause of death.

http://www.eurekalert.org/pub_releases/2014-03/aaon-sad022614.php

[3579] James, B. D., Leurgans S. E., Hebert L. E., Scherr P. A., Yaffe K., & Bennett D. A.
(2014).  Contribution of Alzheimer disease to mortality in the United States.
Neurology. 82(12), 1045 - 1050.

Related News

While everyone agrees that amyloid-beta protein is part of the problem, not everyone agrees that amyloid plaques are the cause (or one of them) of Alzheimer’s. Other forms of amyloid-beta have been pointed to, including floating clumps called oligomers or ADDLs.

A few months ago, I reported on an exciting finding that

The American Academy of Neurology has updated its guidelines on when people with dementia should stop driving.

Another gene has been identified that appears to increase risk of Alzheimer’s. The gene, MTHFD1L, is located on chromosome six.

Previous research has found that unexplained weight loss is an early sign of Alzheimer's.

Amnestic mild cognitive impairment often leads to Alzheimer's disease, but what predicts aMCI?

A pilot study involving 21 institutionalized individuals with moderate-to-severe Alzheimer’s found that, although drinking two 4-oz glasses of apple juice daily for a month produced no change in the Dementia Rating Scale or in the Activities of Daily Living measure, there was a significant (27%)

A pilot study involving 10 patients with moderate Alzheimer's disease, of whom half were randomly assigned to the treatment, has found that two weeks of receiving daily (25 minute) periods of repetitive transcranial magnetic stimulation to the prefrontal

A study involving outpatients with early stage Alzheimer’s found that their performance on some computerized tests of executive function and visual attention, including a simulated driving task, improved significantly after three months of taking

A study involving 54 older adults (66-76) and 58 younger adults (18-35) challenges the idea that age itself causes people to become more risk-averse and to make poorer decisions.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news